Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study
J B Vermorken, G Zanetta, C F De Oliveira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1995
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group
I Teodorovic, S Pittaluga, J C Kluin-Nelemans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
U Tirelli, D Errante, M Van Glabbeke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group
J H Meerwaldt, P Carde, R Somers, et al.
Journal of the National Cancer Institute
|
January 4, 2001
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study
H C Kluin-Nelemans, V Zagonel, A Anastasopoulou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
N S Reed, C Mangioni, H Malmström, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials
E C Moser, E M Noordijk, M van Glabbeke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2003
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)
R E N van Rijswijk, J B Vermorken, N Reed, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 13, 2006
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)
J A Green, E M J J Berns, C Coens, et al.
Advances in Experimental Medicine and Biology
|
December 14, 2006
TuBaFrost: European virtual tumor tissue banking
P H J Riegman, M H A Oomen, W N M Dinjens, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study
J B Vermorken, G Zanetta, C F De Oliveira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1995
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group
I Teodorovic, S Pittaluga, J C Kluin-Nelemans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
U Tirelli, D Errante, M Van Glabbeke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group
J H Meerwaldt, P Carde, R Somers, et al.
Journal of the National Cancer Institute
|
January 4, 2001
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study
H C Kluin-Nelemans, V Zagonel, A Anastasopoulou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
N S Reed, C Mangioni, H Malmström, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials
E C Moser, E M Noordijk, M van Glabbeke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2003
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)
R E N van Rijswijk, J B Vermorken, N Reed, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 13, 2006
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)
J A Green, E M J J Berns, C Coens, et al.
Advances in Experimental Medicine and Biology
|
December 14, 2006
TuBaFrost: European virtual tumor tissue banking
P H J Riegman, M H A Oomen, W N M Dinjens, et al.
Page
of 3